Press release
Impact Of The Growing Geriatric Population On Healthcare Demands: A Significant Driver Propelling The Renal Cell Carcinoma Market In 2025
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.What Is the Renal Cell Carcinoma Market Size and Projected Growth Rate?
The market for renal cell carcinoma has witnessed robust expansion in the last few years. The market is predicted to increase from $0.69 billion in 2024 to $0.74 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.0%. This surge during the historic period can be ascribed to factors such as a higher prevalence of kidney cancer, a growing aging population, a rise in the adoption of targeted therapy approaches, increased consciousness around cancer screenings, enhanced healthcare systems, and an escalation in investment towards oncology research and development.
In the upcoming years, the renal cell carcinoma market size is projected to witness robust growth, expanding to $0.95 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth in the forecast period is primarily due to the increasing acceptance of personalized medicine, escalating consciousness about early cancer diagnosis, increasing investment in oncology by healthcare sector, enhanced healthcare accessibility, and ongoing clinical trials and research on innovative therapies. Major trends expected during this period involve the incorporation of AI for precision diagnosis, the creation of targeted therapies, breakthroughs in immunotherapy, progression in biomarker discovery, embrace of minimally invasive surgical techniques, and advancements in imaging technologies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20944
What Are the Major Segments in the Renal Cell Carcinoma Market?
The renal cell carcinoma market covered in this report is segmented -
1) By Type: Clear Cell Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma (RCC)
2) By Diagnosis: Urine Tests, Computed Tomography (CT) Scan, Nephrectomy, Blood Tests, Ultrasound, Biopsy
3) By Treatment: Medication, Ablation, Targeted Therapy, Chemotherapy, Surgery, Other Treatments
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Clear Cell Renal Cell Carcinoma (RCC): Sporadic Clear Cell RCC, Hereditary Clear Cell RCC
2) By Papillary Renal Cell Carcinoma (RCC): Type 1 Papillary RCC, Type 2 Papillary RCC
3) By Chromophobe Renal Cell Carcinoma (RCC): Classic Chromophobe RCC, Hybrid Chromophobe RCC
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20944&type=smp
What Are The Driving Renal Cell Carcinoma Market Evolution?
The escalating number of older adults is anticipated to propel the expansion of the renal cell carcinoma market in the future. The senior population, typically those aged 65 and over, often have specific health and social needs. The surge in this demographic is propelled by advancements in healthcare, improved nutrition, and extended life expectancies. Renal cell carcinoma (RCC) has a heightened prevalence among senior individuals, emphasizing the necessity for age-specific screening and treatment plans. For instance, a study released by the Population Reference Bureau, a non-profit organization in the US accountable for gathering statistics for research and educational uses, predicted in January 2024 that the count of Americans aged 65 and over is envisaged to escalate from 58 million in 2022 to 82 million by 2050; this represents a 47% increase. Hence, the escalation in the senior population is stimulating the expansion of the renal cell carcinoma market.
Which Firms Dominate The Renal Cell Carcinoma Market Segments?
Major companies operating in the renal cell carcinoma market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Fresenius Kabi AG, GSK plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc. (Mylan N.V.), Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Cipla Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Exelixis Inc., Nektar Therapeutics
What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leading firms in the renal cell carcinoma sector are concentrating on the creation of cutting-edge products, such as implementing AI-driven solutions for kidney biopsy analysis, in an effort to enhance diagnostic accuracy, simplify processes and improve patient outcomes. A solution powered by AI for analysing kidney biopsies is a technology-centric utility that capitalizes on machine learning algorithms and computer vision to assist pathologists and nephrologists in assessing kidney tissue samples. These solutions have been developed with the goal of improving the quality, operational effectiveness, and diagnosing consistency of kidney diseases as well as the evaluation of kidney health. For example, in March 2024, Aiosyn, a software firm based in Netherlands, introduced the NephroPath platform, an innovative AI-powered solution for kidney biopsy analysis. The NephroPath platform employs computational pathology algorithms to examine histological biomarkers in kidney biopsies, which includes recognizing tissue types, gauging interstitial fibrosis, and accurately counting and assessing glomeruli. This AI-facilitated analysis ensures reliable, thorough, and reproducible scoring of renal pathology biomarkers, overcoming the limitations of conventional scoring methods and individual subjectivity.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/renal-cell-carcinoma-global-market-report
Which Is The Largest Region In The Renal Cell Carcinoma Market?
North America was the largest region in the renal cell carcinoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the renal cell carcinoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Renal Cell Carcinoma Market?
2. What is the CAGR expected in the Renal Cell Carcinoma Market?
3. What Are the Key Innovations Transforming the Renal Cell Carcinoma Industry?
4. Which Region Is Leading the Renal Cell Carcinoma Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of The Growing Geriatric Population On Healthcare Demands: A Significant Driver Propelling The Renal Cell Carcinoma Market In 2025 here
News-ID: 4069469 • Views: …
More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…

Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…

Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…

Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…